MilliporeSigma is expanding its Carlsbad, CA facility from 44,000 sq.-ft. to 65,000 sq.-ft., with 16 modular viral bulk manufacturing cleanroom suites, two fill/finish suites and twice the warehouse capacity. The expansion, scheduled for completion in 2016, will incorporate single-use equipment in a flexible, scalable format for clinical and commercial bulk drug production.
 
"We are building on our industry-leading offerings in the manufacturing and testing of innovative and complex products, underscoring our commitment to being a trusted, long-term partner of choice," said Udit Batra, member, executive board, Merck KGaA, Darmstadt, Germany and chief executive officer, MilliporeSigma.
 
The expansion allows the company to support customers from clinical to commercial scales, and is complemented by cell-banking services in Rockville, MD, viral and gene therapy manufacturing capacity in Glasgow, Scotland and global BioReliance biosafety testing offering.